The Effect of Hydroxychloroquine Treatment in Hashimoto's Thyroiditis - Trial NCT01760421
Access comprehensive clinical trial information for NCT01760421 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taiwan University Hospital and is currently Completed. The study focuses on Hashimoto Thyroiditis. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
National Taiwan University Hospital
Timeline & Enrollment
N/A
Oct 01, 2011
Aug 01, 2013
Primary Outcome
Anti-TPO antibody,Anti-thyroglobulin antibody
Summary
Hashimoto's thyroiditis is an autoimmune thyroid disease, which induced chronic inflammation
 of thyroid gland and destroys thyroid tissue.
 
 Hydroxychloroquine is used as disease modifying anti-rheumatic drug (DMARD) for treatment of
 several autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid
 arthritis(RA) for more than one century.
 
 The purpose of this study is to evaluate whether hydroxychloroquine is effective in treatment
 of Hashimoto's thyroiditis.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01760421
Non-Device Trial